Search Results - "KLEIN, Arnaud"
-
1
Genome Editing of Expanded CTG Repeats within the Human DMPK Gene Reduces Nuclear RNA Foci in the Muscle of DM1 Mice
Published in Molecular therapy (07-08-2019)“…Myotonic dystrophy type 1 (DM1) is caused by a CTG repeat expansion located in the 3′ UTR of the DMPK gene. Expanded DMPK transcripts aggregate into nuclear…”
Get full text
Journal Article -
2
Comprehensive transcriptome-wide analysis of spliceopathy correction of myotonic dystrophy using CRISPR-Cas9 in iPSCs-derived cardiomyocytes
Published in Molecular therapy (05-01-2022)“…CTG repeat expansion (CTGexp) is associated with aberrant alternate splicing that contributes to cardiac dysfunction in myotonic dystrophy type 1 (DM1)…”
Get full text
Journal Article -
3
The beneficial effect of chronic muscular exercise on muscle fragility is increased by Prox1 gene transfer in dystrophic mdx muscle
Published in PloS one (18-04-2022)“…Greater muscle fragility is thought to cause the exhaustion of the muscle stem cells during successive degeneration/repair cycles, leading to muscle wasting…”
Get full text
Journal Article -
4
Dystrophin Restoration after Adeno-Associated Virus U7–Mediated Dmd Exon Skipping Is Modulated by Muscular Exercise in the Severe D2-Mdx Duchenne Muscular Dystrophy Murine Model
Published in The American journal of pathology (01-11-2022)“…Duchenne muscular dystrophy (DMD) is a severe neuromuscular disease caused by Dmd mutations, resulting in the absence of dystrophin in skeletal muscle, and a…”
Get full text
Journal Article -
5
Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient-derived cells and mice
Published in The Journal of clinical investigation (01-11-2019)“…Antisense oligonucleotides (ASOs) targeting pathologic RNAs have shown promising therapeutic corrections for many genetic diseases including myotonic dystrophy…”
Get full text
Journal Article -
6
Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells
Published in Nucleic acids research (19-09-2018)“…Abstract CRISPR/Cas9 is an attractive platform to potentially correct dominant genetic diseases by gene editing with unprecedented precision. In the current…”
Get full text
Journal Article -
7
Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds
Published in Disease models & mechanisms (01-04-2017)“…Myotonic dystrophy type 1 (DM1) and type 2 (DM2) are autosomal dominant neuromuscular diseases caused by microsatellite expansions and belong to the family of…”
Get full text
Journal Article -
8
Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy
Published in Nature Medicine (01-06-2011)“…Myotonic dystrophy is a slowly progressing muscle disease marked by muscle wasting and myotonia. Nicolas Charlet-Berguerand and his colleagues have found that…”
Get full text
Journal Article Magazine Article -
9
Improvement of Dystrophic Muscle Fragility by Short-Term Voluntary Exercise through Activation of Calcineurin Pathway in mdx Mice
Published in The American journal of pathology (01-11-2018)“…Dystrophin deficiency in mdx mice, a model for Duchenne muscular dystrophy, leads to muscle weakness revealed by a reduced specific maximal force as well as…”
Get full text
Journal Article -
10
Selective silencing of mutated mRNAs in DM1 by using modified hU7-snRNAs
Published in Nature structural & molecular biology (01-01-2011)“…We describe a function for modified human U7 small nuclear RNAs (hU7-snRNAs) distinct from modification of pre-mRNA splicing events. Engineered hU7-snRNAs…”
Get full text
Journal Article -
11
Cells of Matter- In Vitro Models for Myotonic Dystrophy
Published in Frontiers in neurology (23-05-2018)“…Myotonic dystrophy type 1 (DM1 also known as Steinert disease) is a multisystemic disorder mainly characterized by myotonia, progressive muscle weakness and…”
Get full text
Journal Article -
12
Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells
Published in Molecular therapy. Nucleic acids (13-06-2023)“…Myotonic dystrophy type 1 (DM1) is a neuromuscular disease that originates from an expansion of CTG microsatellites in the 3′ untranslated region of the DMPK…”
Get full text
Journal Article Web Resource -
13
New function for the RNA helicase p68/DDX5 as a modifier of MBNL1 activity on expanded CUG repeats
Published in Nucleic acids research (01-04-2012)“…Myotonic Dystrophy type I (DM1) is caused by an abnormal expansion of CTG triplets in the 3' UTR of the dystrophia myotonica protein kinase (DMPK) gene,…”
Get full text
Journal Article -
14
Reversal of RNA toxicity in myotonic dystrophy via a decoy RNA-binding protein with high affinity for expanded CUG repeats
Published in Nature biomedical engineering (01-02-2022)“…Myotonic dystrophy type 1 (DM1) is an RNA-dominant disease whose pathogenesis stems from the functional loss of muscleblind-like RNA-binding proteins (RBPs),…”
Get full text
Journal Article -
15
Large CTG Repeats Trigger p16-Dependent Premature Senescence in Myotonic Dystrophy Type 1 Muscle Precursor Cells
Published in The American journal of pathology (01-04-2009)“…A CTG repeat amplification is responsible for the dominantly inherited neuromuscular disorder, myotonic dystrophy type 1 (DM1), which is characterized by…”
Get full text
Journal Article -
16
PABPN1 overexpression leads to upregulation of genes encoding nuclear proteins that are sequestered in oculopharyngeal muscular dystrophy nuclear inclusions
Published in Neurobiology of disease (01-04-2005)“…Oculopharyngeal muscular dystrophy (OPMD) is an adult-onset disease caused by expanded (GCN) 12–17 stretches encoding the N-terminal polyalanine domain of the…”
Get full text
Journal Article -
17
PABPN1 polyalanine tract deletion and long expansions modify its aggregation pattern and expression
Published in Experimental cell research (01-05-2008)“…Expansions of a (GCN) 10/polyalanine tract in the Poly(A) Binding Protein Nuclear 1 (PABPN1) cause autosomal dominant oculopharyngeal muscular dystrophy…”
Get full text
Journal Article -
18
The dynamism of PABPN1 nuclear inclusions during the cell cycle
Published in Neurobiology of disease (01-09-2006)“…Oculopharyngeal muscular dystrophy (OPMD) is caused by expansion of a (GCN)10 to a (GCN)11–17 repeat coding for a polyalanine domain at the N-terminal part of…”
Get full text
Journal Article -
19
PGN-EDODM1: Preclinical Data Supporting the Development of an Enhanced Delivery Oligonucleotide (EDO) for the Treatment of Myotonic Dystrophy Type 1 (DM1) (S48.001)
Published in Neurology (25-04-2023)“…Abstract only…”
Get full text
Journal Article -
20